Birdwatch Archive

Birdwatch Note

2023-03-07 03:51:01 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

https://pubmed.ncbi.nlm.nih.gov/35726131/ Ivermectin is not proven to be effective for treatment or prevention of COVID-19 "there is currently low- to high-certainty evidence that ivermectin has no beneficial effect for people with COVID-19. ... No evidence is available on ivermectin to prevent SARS-CoV-2 infection."

Written by 83F8C9FBF04EDF7CE0402610D70596E31ACF4323833A5EAB7FFC83BF5104A1FC
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1632749704206249985

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1632951963112599553
  • noteId - 1632951963112599553
  • participantId - 83F8C9FBF04EDF7CE0402610D70596E31ACF4323833A5EAB7FFC83BF5104A1FC
  • noteAuthorParticipantId -
  • createdAtMillis - 1678161061443
  • tweetId - 1632749704206249985
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 1
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • https://pubmed.ncbi.nlm.nih.gov/35726131/ Ivermectin is not proven to be effective for treatment or prevention of COVID-19 "there is currently low- to high-certainty evidence that ivermectin has no beneficial effect for people with COVID-19. ... No evidence is available on ivermectin to prevent SARS-CoV-2 infection."

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-03-07 03:51:01 UTC
(1678161061443)		 1969-12-31 23:59:59 UTC
(-1)		 2023-03-09 02:09:52 UTC
(1678327792328)		 NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-03-07 19:24:25 -0600 143E87AA7D18550E73ADB263124F543D610930FB5C525972F28F9FE08B79AC45 Rating Details
2023-03-07 00:12:22 -0600 178E883F097938E7AB4307053137C5EE93F75E0BCA40B0D6F2D552C87F3E8ACB Rating Details
2023-03-07 00:58:13 -0600 1C311990A74FF6793E58EA74921ECD5F412D312AD76F6855BEDBE12EF0FF4CA3 Rating Details
2023-03-06 23:13:08 -0600 2129289ACD5E5E0E627173136F9AE9245A2D76292CBC924475680FE820170101 Rating Details
2023-03-06 21:54:07 -0600 29C991F0507FE633C2F69371FB338CD99717F214088C5CD3C65ADA1931661D64 Rating Details
2023-03-07 18:27:47 -0600 2A6D479B09FB3EA0AA7A6E7A17A4CFA5FDEB21681423ADDB5CDF08CF8A81E995 Rating Details
2023-03-07 07:18:24 -0600 2FFED769DA713EEC227A8A925BE54E102FE3BC47BF42BDCF8FC3509C143ECCFB Rating Details
2023-03-07 18:37:27 -0600 3161EFAB823A36466E6AC9F6C0051C2912315D77ED0A82F28BA15DE7AC4E3605 Rating Details
2023-03-07 12:16:52 -0600 407D72098B0DEAD36280743C152D1B50E7DCFCAF19701E7DF495DFBEC867AA1E Rating Details
2023-03-07 02:18:48 -0600 43C0C6E62BBB03EF795C48F090C5C67A52516FE15C8B571592C9BE8300DFD93E Rating Details
2023-03-07 02:09:39 -0600 4408FA4C9188DA49198698D87D78B1C9D372067A4E1AF1939B73B6929B22DF7E Rating Details
2023-03-06 21:54:18 -0600 45060ED935D102E05C21C743FE433C0B17B27D8FCF69CED01A2AD3F9AB2815B1 Rating Details
2023-03-06 23:10:03 -0600 542B365AA9DBAF6479AE44A6744B361E836A8F689384028616C16A54B181189F Rating Details
2023-03-07 21:28:54 -0600 5EDC2B8BBEA2C25FBA40E8849AF6DD751A4AE52F674E4E2311C09F82909AD4F8 Rating Details
2023-03-08 16:26:48 -0600 623F900CD7C9F8C490EF084B063BCAA87DFECDFC5B94A127B70830D86D50EAF5 Rating Details
2023-03-07 05:06:32 -0600 62C490C0BE2044C09866D16465EBCBFEC6A45FFC5BD7B39495D2265A24C14A66 Rating Details
2023-03-06 22:52:38 -0600 78F5BC8300631438AE64DE57D885E01324546660453C9433CF7A5E0257308677 Rating Details
2023-03-07 10:23:58 -0600 8397B8EFF5E66D74E3D766849AAD6651C15A83BE48BE57BF0E5A1A8D5A1A4AE7 Rating Details
2023-03-07 13:41:29 -0600 9633B94214C8D0313E9689B9A79C186DABC5CF2F76C180395173450B7F7808BA Rating Details
2023-03-06 23:43:29 -0600 9736DF42171A999208E640D9616E3AF1D2219C9694E38F806D374F891F58485E Rating Details
2023-03-07 04:15:44 -0600 9C46594DA3BD0515B53647F892CCC7C885B3157576399CA803FCB113AAE2DD01 Rating Details
2023-03-07 07:18:49 -0600 A44876F035713EC16266C9B6E680FFE8FA23356D29801D08E043A05555D9E79E Rating Details
2023-03-06 22:17:10 -0600 ADA7A6B861E84F16A9AC3EE64215DB07837986FF7A1CF25A4D643148B37B51E4 Rating Details
2023-03-07 12:48:37 -0600 B483F9C619AF60464043F7ACD847EBDAF0FEAF04E871DD0AE68077698B2F93F1 Rating Details
2023-03-06 23:43:43 -0600 BCE1617AB1CAE8A24B7EB5E79E218EE63C01A69D41005CA0CD4D289DD3A5A9F8 Rating Details
2023-03-09 03:50:09 -0600 BEDFDC42E9B0AD2B9041AA286147ECD0997A901A98CBEAFD53F181BD20574BFB Rating Details
2023-03-06 23:46:30 -0600 C378931E048482D2BFDF00DC95644D6377CBCB812C79FF87D77B5E48595B3DA3 Rating Details
2023-03-06 22:43:06 -0600 C6E281B73C8DA53CE2FA6F6AA093EC8C211966B1FA566D07562E5C41AF6AF8C3 Rating Details
2023-03-09 17:06:36 -0600 C966E0BA5803EDA2B9ADEA1A226B5D5FB13629349A2D9A920F01C5137F8AF13B Rating Details
2023-03-07 23:16:47 -0600 CAA03362051988C27EED5CDB452B40225425DFFD9383E74818DE69DBAD59B39C Rating Details
2023-03-07 05:03:57 -0600 DA38AF005DDB533CB1A088E86E6DEFF5E0D43D92AA1D705D91657D1C0A998FFE Rating Details
2023-03-09 19:10:52 -0600 E343F092F0B44A6E8DEC7F3A16DFE90A5DA9F420CB1B9EDE2292D0B45E00C827 Rating Details
2023-03-07 05:16:08 -0600 E9C75B9E2E413CA96CD8A37DF8E3DBEE1865C9859064C529388189A80D7D8666 Rating Details
2023-03-06 22:38:52 -0600 E9C91AF0C75B93DB8F159CFEA0E8DCFDAD1FD890BFF2521485F765E60E78E2AF Rating Details
2023-03-11 13:32:16 -0600 EA096DF30477B2B6C0B6C208EB80DA92ABB09381D90B6B92D3850DBB9513B708 Rating Details
2023-03-09 16:41:33 -0600 EB438CF6B4E1C661BB9543EF156E26CB7A8DE887BC6588C08468D52D8D61F352 Rating Details
2023-03-13 22:54:23 -0500 Rating Details
2023-03-20 11:42:34 -0500 Rating Details
2023-03-07 19:24:25 -0600 Rating Details
2023-03-09 17:06:36 -0600 Rating Details
2023-03-06 22:17:10 -0600 Rating Details
2023-03-11 13:32:16 -0600 Rating Details
2023-03-07 12:16:52 -0600 Rating Details
2023-03-07 00:58:13 -0600 Rating Details
2023-03-07 02:18:48 -0600 Rating Details
2023-03-07 18:37:27 -0600 Rating Details
2023-03-06 23:43:29 -0600 Rating Details
2023-03-06 22:43:06 -0600 Rating Details
2023-03-06 22:52:38 -0600 Rating Details
2023-03-09 19:10:52 -0600 Rating Details
2023-03-06 23:46:30 -0600 Rating Details
2023-03-09 16:41:33 -0600 Rating Details
2023-03-06 21:54:18 -0600 Rating Details
2023-03-07 00:12:22 -0600 Rating Details
2023-03-07 10:23:58 -0600 Rating Details
2023-03-07 07:18:49 -0600 Rating Details
2023-03-07 04:15:44 -0600 Rating Details
2023-03-07 07:18:24 -0600 Rating Details
2023-03-06 21:54:07 -0600 Rating Details
2023-03-07 02:09:39 -0600 Rating Details
2023-03-06 23:13:08 -0600 Rating Details
2023-03-07 05:16:08 -0600 Rating Details
2023-03-06 22:38:52 -0600 Rating Details
2023-03-13 22:54:23 -0500 Rating Details
2023-03-06 23:43:43 -0600 Rating Details
2023-03-07 23:16:47 -0600 Rating Details
2023-03-07 05:06:32 -0600 Rating Details
2023-03-08 16:26:48 -0600 Rating Details
2023-03-06 23:10:03 -0600 Rating Details
2023-03-07 13:41:29 -0600 Rating Details
2023-03-07 21:28:54 -0600 Rating Details
2023-03-07 05:03:57 -0600 Rating Details
2023-03-20 11:42:34 -0500 Rating Details
2023-03-07 12:48:37 -0600 Rating Details
2023-03-07 18:27:47 -0600 Rating Details
2023-03-09 03:50:09 -0600 Rating Details